Catalyst Funds Management Pty »

Alnylam Pharmaceuticals shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.3M 21k 301.03
2025-09-30 $3.8M 8.3k 456.00
2025-06-30 $3.5M 11k 326.09
2025-03-31 $5.2M 19k 270.02

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Bloom Energy Corp Ordinary Shares - Class A (BE)
Intel Corp. Ordinary Shares (INTC)
Microsoft Corporation Ordinary Shares (MSFT)
Credo Technology Group Holding Ordinary Shares (CRDO)
Lilly Ordinary Shares (LLY)
Vertiv Holdings Ordinary Shares - Class A (VRT)
Sterling Infrastructure Ordinary Shares (STRL)
Amazon.com Ordinary Shares (AMZN)
Qualcomm Ordinary Shares (QCOM)
Salesforce Ordinary Shares (CRM)
IonQ Ordinary Shares (IONQ)
Nextpower Ordinary Shares - Class A (NXT)
TTM Technologies Ordinary Shares (TTMI)
Fabrinet Ordinary Shares (FN)

View all positions for Catalyst Funds Management Pty

Top funds holding Alnylam Pharmaceuticals

FMR
BlackRock
Capital World Investors
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
Invesco
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Wellington Management Company
Orbis Allan Gray
Dodge & Cox

View all funds holding Alnylam Pharmaceuticals